Clinical Trial Update: Cementless Alumina-Alumina Total Hip and Hybrid [NA]

View source ↗

Summary

Completed clinical trial evaluating a cementless alumina-alumina total hip and hybrid implant for conditions including rheumatoid arthritis and osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis
• Post-traumatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Cementless Alumina-Alumina Total Hip and Hybrid

Snippet

Sponsor: Encore Medical, L.P. | Conditions: Rheumatoid Arthritis, Osteoarthritis | NA | Status: COMPLETED